Audio By Carbonatix
US health regulators have for the first time approved a drug to prevent HIV infection.
Truvada can be used by those at high risk of infection and anyone who may engage in sexual activity with HIV-infected partners, said the Food and Drug Administration (FDA).
Studies showed the drug reduced the risk of contracting HIV by up to 73%.
Some health workers and groups active in the HIV community opposed a green light for the once-daily pill.
There have been concerns the circulation of such a drug could engender a false sense of security and mean people will take more risks. There have also been fears that a drug-resistant strain of HIV could develop.
In a statement, the FDA stressed that the drug should be used as part of a "comprehensive HIV prevention plan", including condom use and regular HIV testing.
In May, an advisory group of health experts recommended approval for the pill.
Truvada, made by California-based Gilead Sciences, is already backed by the FDA to be taken with existing antiretroviral drugs for people who have HIV.
Studies from 2010 showed that Truvada reduced the risk of HIV in healthy gay men - and among HIV-negative heterosexual partners of HIV-positive people - by between 44% and 73%.
Michael Barton of UNAIDS, the Joint United Nations Programme on HIV/AIDS, said there was good trial evidence that the drug could significantly cut the risk of the infection being passed on, but only if the tablets are taken consistently.
Many of the men in the trials did not take the drug regularly enough to get the full protection.
He said that, in most circumstances, it would be better to treat the HIV-positive partner in the couple rather than focus on the HIV-negative one.
"We know that for HIV-positive people if they consistently take antiretroviral drugs and their viral load is suppressed for them it's almost impossible to transmit the virus."
Antiretroviral drugs will also prolong their life.
But he said the new drug might be useful in situations where, for example, a woman has a partner with HIV who is unwilling to take antiretrovirals or use condoms.
Truvada is approved in the UK for the treatment of HIV, but not prevention.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Tags:
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
‘Football in Ghana is about blood and legacy’ – Antoine Semenyo’s mother urges diaspora parents
48 seconds -
QNET, Manchester City bring world-class football coaching to Ghana’s young talent
1 minute -
Emma Ankrah: Between quiet questions and the will to continue
4 minutes -
Ghana’s economy shows strong recovery after “inherited crisis” – Ato Forson tells Parliament
6 minutes -
No further IMF financial bailout will be required in the foreseeable future – Finance Minister
7 minutes -
Learning from Ukraine, Hezbollah is now using fibre-optic drones to hit Israel
8 minutes -
Teenager arrested at Senya Beraku for alleged defilement of 15-year-old girl
8 minutes -
Ghana has moved from IMF ‘supplicant’ to partner – Ato Forson declares as economy surges past $100 Billion
10 minutes -
“Ghana has moved from ICU to wellness center” — Finance Minister declares economic recovery
32 minutes -
Ato Forson highlights “turning point” in economic recovery strategy
35 minutes -
NACSA Seminar: Gender Minister demands an increased role for women to end gun violence
41 minutes -
Full text: Statement on Ghana’s new engagement with IMF
48 minutes -
US trade mission to visit Ghana
1 hour -
Tempane: Three suspects arrested over deadly Worinyanga attacks
1 hour -
EU fines Temu €200m for allowing sale of illegal products
1 hour